Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$4.4 - $6.74 $3,968 - $6,079
-902 Reduced 0.85%
105,057 $693,000
Q4 2023

Feb 13, 2024

BUY
$3.08 - $4.52 $2,553 - $3,747
829 Added 0.79%
105,959 $478,000
Q3 2023

Nov 13, 2023

BUY
$3.47 - $4.61 $12,970 - $17,232
3,738 Added 3.69%
105,130 $376,000
Q2 2023

Aug 04, 2023

BUY
$3.12 - $4.22 $1,073 - $1,451
344 Added 0.34%
101,392 $374,000
Q1 2023

May 12, 2023

BUY
$3.01 - $3.87 $39,536 - $50,832
13,135 Added 14.94%
101,048 $334,000
Q4 2022

Feb 10, 2023

SELL
$2.47 - $3.88 $792 - $1,245
-321 Reduced 0.36%
87,913 $341,000
Q3 2022

Nov 14, 2022

BUY
$2.03 - $2.86 $2,531 - $3,566
1,247 Added 1.43%
88,234 $214,000
Q2 2022

Aug 12, 2022

BUY
$1.43 - $2.2 $124,391 - $191,371
86,987 New
86,987 $172,000
Q2 2021

Aug 13, 2021

SELL
$1.51 - $2.07 $58,002 - $79,512
-38,412 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$1.67 - $2.95 $168 - $297
101 Added 0.26%
38,412 $68,000
Q4 2020

Feb 12, 2021

BUY
$1.8 - $2.56 $4,176 - $5,939
2,320 Added 6.45%
38,311 $75,000
Q3 2020

Nov 04, 2020

SELL
$2.04 - $3.74 $1,670 - $3,063
-819 Reduced 2.22%
35,991 $86,000
Q2 2020

Aug 12, 2020

SELL
$2.42 - $3.29 $11,589 - $15,755
-4,789 Reduced 11.51%
36,810 $108,000
Q1 2020

May 04, 2020

BUY
$1.5 - $4.59 $15,124 - $46,280
10,083 Added 31.99%
41,599 $120,000
Q4 2019

Feb 05, 2020

SELL
$3.89 - $5.15 $1,030 - $1,364
-265 Reduced 0.83%
31,516 $126,000
Q3 2019

Nov 08, 2019

BUY
$3.19 - $5.39 $45,923 - $77,594
14,396 Added 82.81%
31,781 $141,000
Q2 2019

Aug 13, 2019

BUY
$3.52 - $5.24 $17,772 - $26,456
5,049 Added 40.93%
17,385 $67,000
Q1 2019

May 06, 2019

SELL
$2.61 - $4.35 $1,041 - $1,735
-399 Reduced 3.13%
12,336 $47,000
Q4 2018

Feb 13, 2019

SELL
$2.17 - $6.12 $210 - $593
-97 Reduced 0.76%
12,735 $30,000
Q3 2018

Nov 09, 2018

BUY
$4.39 - $6.85 $2,238 - $3,493
510 Added 4.14%
12,832 $80,000
Q2 2018

Aug 08, 2018

BUY
$4.39 - $5.44 $54,093 - $67,031
12,322 New
12,322 $56,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.85B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.